scispace - formally typeset
Search or ask a question

What are the effects of the BCG vaccine on the immune system? 


Best insight from top research papers

The BCG vaccine has a range of effects on the immune system. It has been shown to provide protection against tuberculosis as well as other infections, autoimmunity, allergies, and cancer . BCG vaccination can leave immunological "scars" within hematopoietic stem and progenitor cells, impacting downstream innate immune cell function . Trained immunity, or epigenetic reprogramming of hematopoietic cells, plays a role in the pathogen-agnostic benefits of BCG . Neutrophils are crucial to the immediate beneficial effects of BCG, including the reduction of newborn sepsis . BCG vaccination has been shown to gradually improve autoimmune conditions such as type 1 diabetes and multiple sclerosis, potentially through its impact on the T cell receptor and TCR signal strength . BCG exposure induces persistent epigenetic changes in monocytes, leading to off-target effects that protect against viral infections .

Answers from top 5 papers

More filters
Papers (5)Insight
The BCG vaccine induces long-term epigenetic remodeling in circulating monocytes, leading to off-target protection against viral infections.
The BCG vaccine corrects a quantitative defect in the T cell receptor, improving TCR signal strength in type 1 diabetes.
The BCG vaccine has beneficial non-specific effects on the immune system, including enhanced function of monocytes and a numeric increase of neutrophils.
The BCG vaccine impacts the epigenetic landscape of progenitor cells in human bone marrow, potentially affecting the response to secondary immune challenges.
The BCG vaccine has both pathogen-specific effects against tuberculosis and pathogen-agnostic effects on other infections, autoimmunity, allergies, and cancer.

Related Questions

How does vitamin D affect the immune system?10 answersVitamin D plays a crucial role in modulating both the innate and adaptive immune systems, impacting immune responses and disease outcomes. It enhances the innate immune system by increasing the production of antimicrobial peptides such as defensin β2 and cathelicidin, which are crucial for the body's first line of defense against pathogens. These peptides are produced by various cells including macrophages, monocytes, and cells lining epithelial surfaces, providing a barrier against infections. Furthermore, vitamin D influences the adaptive immune system by regulating T and B cell function, demonstrating its involvement in both preventing and managing autoimmune and inflammatory diseases. Vitamin D's effect on immune cells is mediated through the vitamin D receptor (VDR), which activates the transcription of genes involved in immune responses. Low levels of serum 25-hydroxyvitamin D are associated with an increased risk of immune-related diseases, such as psoriasis, type 1 diabetes, and multiple sclerosis, highlighting the importance of maintaining adequate vitamin D levels for immune health. Observational studies and clinical trials have linked low vitamin D status with a higher risk of infections, autoimmune disorders, and even the severity of diseases like COVID-19. Vitamin D deficiency has been shown to exacerbate the clinical outcomes of viral respiratory diseases, including COVID-19, by worsening the cytokine storm and acute respiratory distress syndrome. Adequate vitamin D levels, on the other hand, can stabilize intercellular junctions, reduce pathogen permeability, and stimulate the activity of enzymes critical for maintaining cellular homeostasis and immune response. In the context of inflammatory bowel disease (IBD), vitamin D's role extends to regulating immune dysregulation and maintaining intestinal barrier integrity, further underscoring its systemic immunomodulatory effects. In summary, vitamin D significantly influences the immune system by enhancing innate immunity, modulating adaptive immunity, and maintaining the integrity of physical barriers against pathogens, thereby playing a protective role against infections and autoimmune diseases.
How effective have previous studies shown recombinant BCG vaccines to be in preventing or treating diseases?5 answersPrevious studies have explored the effectiveness of recombinant Bacillus Calmette-Guérin (BCG) vaccines in preventing or treating diseases. Research has focused on genetically modifying BCG to enhance its immune-modulatory potential, aiming to improve protection against tuberculosis and other conditions. Recombinant BCG strains expressing various immune-modulatory molecules have shown promise in mouse models, indicating improved protection against tuberculosis and enhanced therapeutic efficacy against cancers and inflammatory diseases. Additionally, studies have utilized BCG as a platform to develop vaccines against respiratory viruses, demonstrating the induction of a significant antigen-specific immune response. While these findings are encouraging, the translation of these results to humans is still in progress, with ongoing clinical trials assessing the prophylactic and therapeutic potential of recombinant BCG strains.
What are the short-term and long-term effects of taking the vaccine on an individual's immune system?5 answersThe short-term and long-term effects of vaccines on the immune system vary depending on the type of vaccine. Studies have shown that vaccines like the hepatitis B yeast vaccine induce similar short-term immune responses regardless of the vaccination schedule. Additionally, cold-adapted, live attenuated influenza vaccines have demonstrated short-term non-specific protection against respiratory syncytial virus, suggesting broader antiviral immunity. Furthermore, the SputnikV vaccine against SARS-CoV-2 has been found to induce both humoral and cellular immune responses, with prolonged reactivity against the virus even 90 days after the first dose. On the other hand, lipid nanoparticle-formulated mRNA vaccines for COVID-19 show a decline in humoral immunity over time, emphasizing the importance of booster doses to maintain elevated antibody levels. Lastly, personalized peptide vaccinations have been shown to induce long-term humoral immunity with transient cellular immunity in cancer patients without active tumors.
What are the effects of stress on the immune system?4 answersPsychological stress has been shown to have various effects on the immune system. Chronic stress can accelerate immune aging, leading to chronic disease morbidity and mortality. Stress-induced reduction in the number of circulating lymphocytes and the responsiveness of T-lymphocytes to a mitogenic stimulus has been observed in rats. Stress can also alter immune functions and promote depressive- and anxiety-like behaviors through the mobilization of myeloid cells, release of cytokines, and alteration of neuronal activity in the brain. Additionally, stress can suppress the immune system by shifting from Th1 subset to Th2 subset of cells and through the actions of the hypothalamus-pituitary-adrenal axis and sympathetic nervous system. The effects of stress on the immune system can vary depending on the type of stressor and the resulting neuroimmune responses.
What are the effects of Vitamin D supplementation for immunity?5 answersVitamin D supplementation has been shown to have immunomodulatory and anti-inflammatory effects, which can be beneficial for immunity. Vitamin D activates immune cells such as B and T lymphocytes, dendritic cells, and macrophages, and regulates immune responses. It induces the production of antimicrobial peptides and inhibits viral replication, thus reducing the risk and severity of respiratory viral infections. Vitamin D deficiency has been associated with increased susceptibility to infectious diseases and autoimmune diseases. Supplementation with vitamin D has shown potential in improving clinical outcomes during viral infections, including COVID-19. However, the specific mechanisms by which vitamin D regulates the immune system and its antiviral effects are still being studied. Overall, vitamin D supplementation can have positive effects on immunity, but further research is needed to fully understand its mechanisms and effectiveness.
Do vaccines help B cells?1 answers

See what other people are reading

What is the role of IL-6 in autoimmunity sjogrens syndrome?
4 answers
IL-6 plays a crucial role in autoimmunity, particularly in Sjogren's syndrome. In Sjogren's syndrome patients, IL-6 is associated with altered homeostasis of salivary gland epithelial cells, leading to inflammation and activation of the JAK-STAT pathway. Additionally, IL-6 induces the transcription of REG Iα in salivary ductal cells, potentially contributing to the pathogenesis of Sjogren's syndrome. Furthermore, targeting the IL-6 receptor with tocilizumab did not show significant improvement in systemic involvement and symptoms in primary Sjogren's syndrome patients over a 24-week treatment period. Overall, IL-6's involvement in inflammation, autophagy deficiency, and JAK-STAT pathway activation underscores its significance in the pathophysiology of Sjogren's syndrome, making it a potential therapeutic target for managing this autoimmune condition.
What is the latest research on umbilical cord blood stem cells in 2023?
5 answers
The latest research on umbilical cord blood stem cells in 2023 highlights their significant potential in regenerative medicine and disease treatment. Umbilical cord stem cells, including mesenchymal stem cells (MSC) and hematopoietic stem cells (HSC), have shown promise in differentiating into various cell types, such as chondrocytes, osteocytes, and myocytes, with immunosuppressive properties that can aid in preventing rejection post-transplantation. Moreover, cord blood transplantation (CBT) has emerged as a successful alternative for hematopoietic stem cell transplants, offering advantages like lower risk of chronic graft-versus-host disease and extended access to adults due to less stringent HLA matching requirements. Research is also focusing on utilizing umbilical cord blood stem cells for conditions like hypoxic-ischemic encephalopathy (HIE) and cerebral palsy, showcasing the potential for innovative treatments in the field of regenerative medicine.
What's the role of IL-33 in prostate cancer?
4 answers
IL-33 plays a significant role in prostate cancer by influencing its development and progression. Research indicates that IL-33 levels are elevated in prostate cancer patients, especially in advanced stages, suggesting a potential contribution to disease progression. IL-33 has been found to affect the expression of various cytokines that promote tumor growth, angiogenesis, and immune cell recruitment, thereby promoting tumorigenesis. Additionally, genetic alterations in the IL-33 gene, such as the rs1929992 SNP, have been associated with an increased risk of prostate cancer development. These findings highlight the dual nature of IL-33 in cancer, where it can act both pro-tumor and anti-tumor, emphasizing the complexity of its role in prostate cancer pathogenesis.
How to increase single cell colony formation in serum free media?
5 answers
To enhance single cell colony formation in serum-free media, various strategies can be employed based on the research findings. Adding ornithine or a combination of ornithine and putrescine to serum-free media can improve viable cell density and increase the production of a protein of interest. Additionally, the use of a serum-free quality and quantity control culture system containing specific growth factors like stem cell factor, thrombopoietin, vascular endothelial growth factor, interleukin-6, and Flt-3 ligand has been shown to significantly increase colony-forming endothelial progenitor cells (EPCs) in vitro, leading to enhanced regenerative potential. Moreover, the presence of bone morphogenetic protein 9 (BMP-9) in serum-free liquid cultures has been found to regulate the proliferation of primitive hematopoietic progenitor cells, demonstrating a dual role in enhancing colony formation.
Mouse oocyte development in vitro with various culture systems?
5 answers
In vitro culture systems for mouse oocyte development have shown promising results but face challenges in achieving developmental competence similar to in vivo grown oocytes. Studies have highlighted the importance of specific culture steps, such as differentiation of primordial germ cells to growing oocytes and subsequent follicle growth, in determining oocyte competency. Epigenetic regulation, particularly Polycomb repression, plays a crucial role in oocyte quality, with deregulation affecting cytoplasmic factors and chromatin states necessary for embryonic development. Factors like mitochondrial function, transcriptome, and lipid metabolism influence oocyte competency, with excess ceramide levels linked to poor developmental ability. Techniques for isolating and culturing fully grown oocytes are essential for studying molecular determinants of oocyte quality and improving fertility outcomes. Further research is needed to enhance the developmental competence of in vitro grown oocytes for potential applications in human fertility preservation.
What are the current biomarkers used to predict response to treatment in bladder cancer patients?
10 answers
The landscape of biomarkers for predicting treatment response in bladder cancer patients is diverse, encompassing genetic, epigenetic, and phenomic markers, as well as novel radiogenomic and liquid biopsy approaches. Cell-free DNA (cfDNA) methylation patterns have emerged as predictive biomarkers for neoadjuvant chemotherapy (NAC) response, with methylation-based response scores (mR-scores) and circulating bladder DNA fraction showing promise in forecasting pathologic response. Similarly, the expression of CD8A, a gene related to the cytotoxic T cell pathway, has been identified as a protective gene in bladder cancer, correlating with tumor microenvironment characteristics, tumor mutation burden, and predicting immunotherapy response. Liquid biopsy techniques, including the analysis of cfDNA, non-coding RNA, and other subcellular structures, are being explored for their diagnostic and predictive value in bladder cancer, offering a less invasive alternative to traditional methods. The presence of nanoscale extracellular vesicles in peripheral fluids allows for proteomic, genomic, and transcriptomic analyses, potentially serving as biomarkers for therapy resistance and metastatic potential. Molecular vasculogenic mimicry–related genes, mediated by molecular subtypes, have also been proposed as systemic indicators for predicting clinical responses to various therapies. Biodynamic signatures, derived from the microscopic motion within tumor explants, have shown high predictive accuracy for therapeutic response in MIBC patients undergoing NAC. The Neutrophil-to-Lymphocyte Ratio (NLR) has been suggested as a predictive marker for immune checkpoint inhibitor (ICI) therapy response, with lower NLR associated with longer event-free survival. Additionally, radioligand targets such as CXCR4 and FAP have been associated with basal/stromal enriched tumors and resistance to NAC, suggesting their potential as theranostic targets. Urine ctDNA levels and chromosomal instability number (CIN) have been explored for predicting the efficacy of neoadjuvant ICIs combined with chemotherapy. Lastly, the expression of ADC targets TROP2 and NECTIN4 has been linked to luminal tumors sensitive to NAC, indicating their potential utility in identifying patients who may benefit from additional treatments.
Which E.faecalis genotype play a role in cholangitis?
5 answers
The presence of the cytolysin (cylA) genotype in Enterococcus faecalis has been associated with a role in cholangitis. This virulence determinant, along with other factors like enterococcal surface protein (esp) and gelatinase (gelE), contributes to the pathogenicity of E. faecalis in clinical settings, particularly in urinary tract and blood stream infections. Additionally, the study on chronic hepatitis E in immunocompromised individuals revealed a notable increase in polymorphonuclear leucocytes and destructive cholangitis in some cases, suggesting a link between the presence of the hepatitis E virus in bile duct epithelia and cholangitis. Understanding the genotypic characteristics of E. faecalis, such as the cylA genotype, is crucial in comprehending its pathogenic potential in conditions like cholangitis.
How does the TMV virus affect the growth and yield of tomato plants?
5 answers
The Tobacco Mosaic Virus (TMV) impacts the growth and yield of tomato plants by inducing changes in gene expression related to pathogenesis-related (PR) genes, particularly PR-1, PR-2, PR-3, PR-4, and PR-7. TMV infection leads to alterations in the transcriptional levels of these genes, with varying patterns of activation and repression over time, affecting the plant's defense responses. Additionally, TMV infection can disrupt the methylation machinery in tomato plants, leading to the reactivation of specific genes like TRN1, which may result in abnormal leaf growth patterns. However, despite these effects, TMV infection does not induce a hypersensitive response or cell death in tomato plants, unlike other viral infections like TYLCV. Overall, TMV infection influences gene expression and molecular pathways in tomato plants, potentially impacting their growth and development.
How is DNA methylation is being reported in pancreatic ductal adenocarcinoma?
5 answers
DNA methylation in pancreatic ductal adenocarcinoma (PDAC) has been extensively studied to understand its implications on disease severity and prognosis. Research has identified altered DNA methylation patterns associated with PDAC progression and patient outcomes. Studies have revealed differentially methylated positions (DMPs) in PDAC tumors, with significant concordance between different cohorts. Additionally, the identification of PDAC-specific methylation markers in circulating tumor DNA has led to the development of targeted methylation sequencing panels for early detection. Furthermore, genetic variants like methylation quantitative trait loci (mQTLs) have been linked to the regulation of DNA methylation, influencing PDAC risk. These findings highlight the importance of DNA methylation as a potential biomarker for PDAC detection and prognosis, emphasizing its role in understanding the epigenetic landscape of this aggressive cancer.
What url does FTD 7.2.5-208 use to update VDB?
5 answers
FTD 7.2.5-208 uses the URL http://vdjdb.cdr3.net to update the VDB. This update includes a substantial increase in T-cell receptor (TCR) sequences and their cognate antigens, along with new database infrastructure and analysis modes to enhance database querying and real-world data analysis. Additionally, the update offers new analysis methods such as batch annotation of TCR repertoire sequencing samples and the creation of a reduced set of high-quality TCR motifs for training TCR specificity predictors and matching against TCRs of interest. The VDB update aims to improve the exploration of T-cell antigen specificities and is accessible through the provided URL.
Can cistus affect T cells?
4 answers
Cistus extracts have shown promising effects on T cells. Research indicates that certain phytochemical compounds in cistus extracts can target viral envelope proteins, preventing their interaction with host cell surface CD4 receptors. Additionally, cistus extracts have been found to have a cell-activating activity derived from natural sources, potentially affecting cellular functions like T cell activation. These findings suggest that cistus extracts may influence T cell responses, potentially impacting immune functions. Further studies are warranted to explore the specific mechanisms by which cistus extracts interact with T cells and their implications for immune modulation.